嵌合抗原受体
抗原
CD19
癌症研究
肿瘤微环境
免疫检查点
免疫系统
T细胞
癌症
癌细胞
免疫学
免疫疗法
医学
内科学
作者
Kheng Newick,Edmund K. Moon,Steven Μ. Albelda
摘要
Chimeric antigen receptor (CAR) T cells are engineered constructs composed of synthetic receptors that direct T cells to surface antigens for subsequent elimination. Many CAR constructs are also manufactured with elements that augment T-cell persistence and activity. To date, CAR T cells have demonstrated tremendous success in eradicating hematological malignancies (e.g., CD19 CARs in leukemias). This success is not yet extrapolated to solid tumors, and the reasons for this are being actively investigated. Here in this mini-review, we discuss some of the key hurdles encountered by CAR T cells in the solid tumor microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI